Cardiac Arrhythmia Suppression Trial (CAST)

NCT00000526 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Disease
Death, Sudden, Cardiac
Heart Arrest
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Ventricular Arrhythmia

Interventions

DRUG: encainide
DRUG: flecainide
DRUG: moricizine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)